Redeye is positive about Optomed´s launch of its next-gen camera, Optomed Lumo.
Redeye provides commentary on NextCell following recent newsflow including raising SEK36.
Redeye concludes that Systemair is able to show firm margins despite a muted topline in their fourth...
Redeye provides a brief comment on today’s news regarding Scibase's first order in Italy.
Redeye is positive about SynAct’s new directed issue and loan agreement with Hunter Capital, both of...
Redeye comments on Enviro’s press release from last Friday, stating that Infiniteria (the joint vent...
Analysguiden ser potentialen i Studentbostäder i Norden och målet om en belåningsgrad om max 60% til...
Redeye leaves a short comment on the final outcome of Iconovo’s fully guaranteed rights issue.
Redeye returns with a more in-depth take on the Q4 results.
Redeye updates its outlook on Genovis following a Q1 report coming in slightly above our estimates a...
Redeye return with a research update following BioArctic's Q1 report and capital markets day.
CEO Arni Ekholm has decided to retire on March 2026.
Redeye comments on Jumpgate’s announcement regarding the approval of SEK13.
Q1 figures above ABGSCe Minor underlying changes, applying our latest oil market view Fair value ran...
Fastator minskar både omsättning och förlust kraftigt i det första kvartalet.
